Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice
- 3 May 2012
- journal article
- research article
- Published by Springer Nature in Translational Stroke Research
- Vol. 3 (3) , 381-389
Abstract
Blood coagulation factor XI (FXI) is an established risk factor for acute ischemic stroke (AIS) and thrombosis, but is also needed for normal hemostasis. Contact factor XII (FXII), an upstream activator of FXI, also contributes to experimental stroke, but is not required for hemostasis. We investigated whether selectively inhibiting FXII-mediated FXI activation, while leaving other FXI and FXII functions intact, could improve the outcome of experimental AIS in mice. Twenty-four hours before induction of AIS by placement of a filament into the internal carotid artery for 60 min, mice were anticoagulated with an antibody directed against the apple 2 domain of FXI. This antibody selectively reduces the prothrombotic activation of FXI by FXIIa but does not affect activated FXI or hemostatic activation of FXI by thrombin, thus leaving hemostasis intact in mice and primates. In this model of AIS/reperfusion injury, mice that received the antibody before AIS displayed less ischemic damage, manifested as reduced cerebral infarction and fibrin deposition (thrombosis), increased cortical reperfusion, and improved neurological behavior. Further, the antibody-anticoagulated mice had no detectable hemostasis impairment. Consistent with the neuroprotective phenotype of FXII-deficient mice, our data suggest that a single molecular event, FXII-mediated FXI activation, contributes to the development of experimental AIS.Keywords
This publication has 34 references indexed in Scilit:
- Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular eventsThrombosis Research, 2011
- Multiple Preconditioning Paradigms Converge on Interferon Regulatory Factor-Dependent Signaling to Promote Tolerance to Ischemic Brain InjuryThe Journal of Neuroscience, 2011
- Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular eventsEuropean Journal of Clinical Investigation, 2011
- Thrombin Mutant W215A/E217A Treatment Improves Neurological Outcome and Reduces Cerebral Infarct Size in a Mouse Model of Ischemic StrokeStroke, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- A role for factor XIIa–mediated factor XI activation in thrombus formation in vivoBlood, 2010
- Novel Hemostatic Factor Levels and Risk of Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) StudyCerebrovascular Diseases, 2010
- Tissue FactorArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Factor XI contributes to thrombin generation in the absence of factor XIIBlood, 2009
- Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XIBlood, 2009